MedPath

Effect of Vibhitakadi Ghrita and Triphaladi compound orally and Rajnidaaru eye drops in Dry Eye Syndrome

Phase 2
Conditions
Health Condition 1: H049- Disorder of lacrimal system, unspecified
Registration Number
CTRI/2023/07/055133
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either sex aged between 21 to 60 years.

2.Patient is willing and able to participate in the study.

3.Patients presenting with sign and symptoms of Dry eye syndrome and lakshana of Shushkakshipaka as described in the text.

Exclusion Criteria

1.Severe cases of dry eye syndrome with complications like corneal ulcers, uveitis, glaucoma etc.

2.Allergic and inflammatory conditions of eye e.g., Acute Conjunctivitis, Vernal Keratoconjunctivitis, giant papillary conjunctivitis etc.

3.Patients on steroids, oral contraceptive pills, oestrogen replacement therapy, or any other medication such as antispasmodic drugs such as Atropine that may adversely affect the outcome of study.

4.Patients suffering from major systemic illness necessitating long term treatment ex. Psycho-epileptic drug users etc.

5.H/o hypersensitivity to the trial drug or any of its ingredients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in foreign body sensation in Shushkakshipaka w.s.r. to Dry eye syndrome assessed through specific questionnaire & tools.Timepoint: 42 days
Secondary Outcome Measures
NameTimeMethod
Changes in the quality of life will be assessed according to OSDI Chart.Timepoint: 42 days
© Copyright 2025. All Rights Reserved by MedPath